Metoprolol Tartrate/Flexmed (Metoprolol Tartrate)

The drug selectively blocks β1‑adrenergic receptors in the heart, which slows the heart rate, reduces the force of contraction, and lowers cardiac output. This also diminishes renin release from the kidneys, contributing to blood‑pressure reduction and decreasing myocardial oxygen demand, thereby alleviating angina and stabilising arrhythmias.

The specific dose and infusion rate are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals tailor the regimen to individual needs, and the product label provides guidance for appropriate titration and monitoring.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Metoprolol Tartrate is a short‑acting, β1‑selective blocker, offering rapid onset when given intravenously, which is useful in acute settings such as myocardial infarction. Compared with longer‑acting agents like atenolol or propranolol, it allows tighter titration and quicker withdrawal, but requires careful monitoring due to its potent cardiac effects.

Metoprolol Tartrate/Flexmed must be stored at 2‑8 °C, kept refrigerated, protected from light, and should never be frozen or shaken. The vial should remain in its original packaging until use to maintain stability and sterility.

The medication is supplied as a sterile injectable solution for intravenous infusion. It is administered by a qualified healthcare professional, typically via a controlled infusion pump or slow IV push, following the dosing instructions provided by the prescriber and adhering to aseptic technique.

Serious risks include severe bradycardia, heart block, bronchospasm in patients with reactive airway disease, acute heart failure, and rare allergic reactions such as anaphylaxis. Prompt recognition and immediate medical intervention are essential if any of these events occur.

Metoprolol Tartrate is contraindicated in patients with known hypersensitivity to the drug, those experiencing severe bradycardia, second‑ or third‑degree AV block without a pacemaker, cardiogenic shock, and in individuals with uncontrolled asthma or severe chronic obstructive pulmonary disease where β‑blockade may precipitate bronchospasm.